Acadia Pharmaceuticals Inc (ACAD) stock
ACADNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3041% below fair value
$18.75+0.61 (+3.36%)
Close on Nov 13, 2026Market cap $3.23BP/E 8.9Yield –
Acadia Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Acadia Pharmaceuticals's operating margin for the twelve months ending Sep 30, 2026 was 10.2%. For fiscal 2025 it was 9.8%, against 24.1% the year before. The highest annual figure on record is 35.8% in fiscal 2010.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9.8% | −14.3 |
| FY2024 | Dec 31, 2024 | 24.1% | +34.2 |
| FY2023 | Dec 31, 2023 | -10.1% | +33.1 |
| FY2022 | Dec 31, 2022 | -43.2% | −8.0 |
| FY2021 | Dec 31, 2021 | -35.2% | +29.7 |
| FY2020 | Dec 31, 2020 | -64.9% | +7.8 |
| FY2019 | Dec 31, 2019 | -72.7% | +37.9 |
| FY2018 | Dec 31, 2018 | -110.6% | +123.6 |
| FY2017 | Dec 31, 2017 | -234.1% | +1340.0 |
| FY2016 | Dec 31, 2016 | -1574.1% | +268281.6 |
| FY2015 | Dec 31, 2015 | -269855.7% | −192164.1 |
| FY2014 | Dec 31, 2014 | -77691.7% | −74347.0 |
| FY2013 | Dec 31, 2013 | -3344.7% | −2919.1 |
| FY2012 | Dec 31, 2012 | -425.6% | +679.9 |
| FY2011 | Dec 31, 2011 | -1105.6% | −1141.4 |
| FY2010 | Dec 31, 2010 | 35.8% | +746.4 |
| FY2009 | Dec 31, 2009 | -710.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 21.0% | +8.1 |
| Q2 FY2026 | Jun 30, 2026 | 12.3% | +0.0 |
| Q1 FY2026 | Mar 31, 2026 | -1.7% | −9.6 |
| Q4 FY2025 | Dec 31, 2025 | 6.1% | −53.0 |
| Q3 FY2025 | Sep 30, 2025 | 12.8% | +0.2 |
| Q2 FY2025 | Jun 30, 2025 | 12.2% | −0.3 |
| Q1 FY2025 | Mar 31, 2025 | 7.9% | +0.5 |
| Q4 FY2024 | Dec 31, 2024 | 59.1% | +44.0 |
| Q3 FY2024 | Sep 30, 2024 | 12.6% | +39.9 |
| Q2 FY2024 | Jun 30, 2024 | 12.6% | +10.7 |
| Q1 FY2024 | Mar 31, 2024 | 7.4% | +52.6 |
| Q4 FY2023 | Dec 31, 2023 | 15.1% | +48.9 |
| Q3 FY2023 | Sep 30, 2023 | -27.3% | −3.7 |
| Q2 FY2023 | Jun 30, 2023 | 1.8% | +26.8 |
| Q1 FY2023 | Mar 31, 2023 | -45.2% | +52.6 |
| Q4 FY2022 | Dec 31, 2022 | -33.7% | +0.4 |
| Q3 FY2022 | Sep 30, 2022 | -23.6% | −12.0 |
| Q2 FY2022 | Jun 30, 2022 | -25.0% | +12.9 |
| Q1 FY2022 | Mar 31, 2022 | -97.9% | −35.2 |
| Q4 FY2021 | Dec 31, 2021 | -34.2% | +21.4 |
| Q3 FY2021 | Sep 30, 2021 | -11.6% | +59.6 |
| Q2 FY2021 | Jun 30, 2021 | -37.9% | +2.0 |
| Q1 FY2021 | Mar 31, 2021 | -62.7% | +36.7 |
| Q4 FY2020 | Dec 31, 2020 | -55.5% | +1.9 |
| Q3 FY2020 | Sep 30, 2020 | -71.2% | −23.2 |
| Q2 FY2020 | Jun 30, 2020 | -40.0% | +28.6 |
| Q1 FY2020 | Mar 31, 2020 | -99.4% | +39.8 |
| Q4 FY2019 | Dec 31, 2019 | -57.4% | +55.6 |
| Q3 FY2019 | Sep 30, 2019 | -48.0% | +57.1 |
| Q2 FY2019 | Jun 30, 2019 | -68.6% | +43.7 |
| Q1 FY2019 | Mar 31, 2019 | -139.2% | −27.0 |
| Q4 FY2018 | Dec 31, 2018 | -112.9% | +47.8 |
| Q3 FY2018 | Sep 30, 2018 | -105.1% | +79.4 |
| Q2 FY2018 | Jun 30, 2018 | -112.3% | +111.0 |
| Q1 FY2018 | Mar 31, 2018 | -112.2% | +468.2 |
| Q4 FY2017 | Dec 31, 2017 | -160.7% | +493.3 |
| Q3 FY2017 | Sep 30, 2017 | -184.5% | – |
| Q2 FY2017 | Jun 30, 2017 | -223.3% | – |
| Q1 FY2017 | Mar 31, 2017 | -580.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -654.0% | – |
See a number that looks wrong?